skip navigation

Skip Nav


Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms - February 23, 2010

Date: February 23, 2010


The U.S. Food and Drug Administration (FDA) is reviewing clinical trial data about a potentially serious effect on the heart from the use of Invirase (saquinavir) in combination with Norvir (ritonavir). The data suggest that together the two drugs may affect the electrical activity of the heart.

Back to Top